Detalhe da pesquisa
1.
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
N Engl J Med
; 367(18): 1694-703, 2012 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23020132
2.
Learning and confirming with preclinical studies: modeling and simulation in the discovery of GDC-0917, an inhibitor of apoptosis proteins antagonist.
Drug Metab Dispos
; 41(12): 2104-13, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24041744
3.
Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours.
EClinicalMedicine
; 49: 101430, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747193
4.
A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma.
Clin Genitourin Cancer
; 19(5): 434-446, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006498
5.
A phase I/II study of carfilzomib 2-10-min infusion in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 72(4): 861-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23975329